Michael Grant, MD, explores how clinicians can overcome real-world barriers to molecular testing in resected NSCLC.

An expert discusses the evolution of ROS1 testing in non-small cell lung cancer, highlighting the shift from FISH-based methods to comprehensive next-generation sequencing of both tissue and plasma, ...

Researchers at Dartmouth Hitchcock Medical Center have developed a way to diagnose Lyme disease earlier and more accurately than traditional testing methods. Over the past 30 years, Lyme disease has ...

CT screening for lung cancer could save countless lives, but low participation rates have led to some eyebrow-raising proposals. Molecular methods, touted by those with a vested interest, promise to ...

Pragmatic, Multicenter, Double-Blind Evaluation of Circulating Cancer-Associated Macrophage-Like Cells for Detection of Cancer in Indeterminate Pulmonary Nodules A decision tree for molecular ...

A new era in tuberculosis care has begun with the introduction of a highly affordable molecular test, priced at just $2.60.

A new perspective paper explores the current state and future directions of precision medicine in colorectal cancer (CRC). It outlines advancements in molecular testing and their implications for ...

Current Practices, Perceived Barriers, and Promising Implementation Strategies for Improving Quality of Smoking Cessation Support in Accredited Cancer Programs of the American College of Surgeons This ...

When working with research peptides, quality and consistency are important factors. A peptide may look similar to another ...

Built in a matter of months, Seek Labs’ functional investigational prototype delivers point-of-care Mycobacterium tuberculosis detection without instrumentation, electricity, or lab infrastructure.